Boron compounds: New candidates for boron carriers in BNCT

Neutron Capture Therapy: Principles and Applications

Volumn 9783642313349, Issue , 2012, Pages 99-116

  Nakamura, Hiroyuki ^a   Kirihata, Mitsunori ^b  

^a GAKUSHUIN UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901832904     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-31334-9_7     Document Type: Chapter

References (79)

1. Soloway AH, Tjarks W, Barnum BA et al (1998) The chemistry of neutron capture therapy. Chem Rev 98:1515-1562
2. Hawthorne MF (1993) The role of chemistry in the development of boron neutron capture therapy of cancer. Angew Chem Int Ed Engl 32:950-984
3. Barth RF, Soloway AH, Fairchild RG et al (1992) Boron neutron capture therapy for cancer, realities and prospects. Cancer 70:2995-3007
4. Soloway AH, Hatanaka H, Davis MA (1967) Penetration of brain and brain tumor. VII. Tumorbinding sulfhydryl boron compounds. J Med Chem 10:714-717
5. Snyder HR, Reedy AJ, Lennarz WJ (1958) Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acid analog of tyrosine. J Am Chem Soc 80:835
6. Nakagawa Y, Hatanaka H (1997) Boron neutron capture therapy. Clinical brain tumor studies. J Neurooncol 33:105-115
7. Mishima Y, Ichihashi M, Hatta S et al (1989) New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to fi rst clinical trial, pigment. Cell Res 2:226-234
8. Kato I, Ono K, Sakurai Y et al (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61:1069-1073
9. Aihara T, Hiratsuka J, Morita N et al (2006) First clinical case of boron neutron capture therapy for head and neck malignancies using 18 F-BPA PET. Head Neck 28:850-855
10. Suzuki M, Sakurai Y, Hagiwara S et al (2007) First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma. Jpn J Clin Oncol 37:376-381
11. Adams L, Hosmane SN, Eklund JE et al (2002) A new synthetic route to boron-10 enriched pentaborane(9) from boric acid and its conversion to anti-10 B 18 H 22. J Am Chem Soc 124:7292-7293
12. El-Zaria ME, Dorfler U, Gabel D (2002) Synthesis of (aminoalkylamine)-N-aminoalkyl) azanonaborane(11) derivatives for boron neutron capture therapy. J Med Chem 45:5817-5819
13. Srivastava RR, Singhaus RR, Kabalka GW (1999) 4-Dihydroxyborylphenyl analogues of 1-aminocyclobutanecarboxylic acids: potential boron neutron capture therapy agents. J Org Chem 64:8495-8500
14. Kabalka GW, Wu ZZ, Yao M-L et al (2004) The syntheses and in vivo biodistribution of novel boronated unnatural amino acids. Appl Radiat Isot 61:1111-1115
15. Slepukhina I, Gabel D, (2006) Synthesis and in vitro toxicity of new dodecaborate-containing amino acids. In: Nakagawa Y, Kobayashi T, Fukuda H. (eds.) Proceedings of ICNCT-12:247-250
16. Hattori Y, Kurihara K, Niki Y et al (2006) Synthesis and evaluation of the compounds containing 10 B and 19 F atoms as boron carrier and imaging agent. Peptide Sci 2005:337-340
17. Dewar MJS, Maitlis PM (1959) A boron-containing purine analog. J Am Chem Soc 81: 6329-6330
18. Matteson DS, Cheng T-C (1968) Displacement reactions of dibutyl iodomethaneboronate and the synthesis of boron-substituted pyrimidines. J Org Chem 33:3055-3060
19. Al-Madhoun AS, Johnsamuel J, Barth RF et al (2004) Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res 64:6280-6286
20. Olejniczak AB, Plesek J, Lesnikowski ZJ (2006) Nucleoside-metallacarborane conjugates for base-speci fi c metal labeling of DNA. Chem Eur J 13:311-318
21. Kahl SB, Koo MS (1990) Synthesis of tetrakis-carborane-carboxylate esters of 2, 4-bis-( a , b-dihydroxyethyl)-deuteroporphyrin IX. Chem Commun 1769-1771
22. Hill JS, Kahl SB, Kaye AH et al (1992) Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci USA 89:1785-1789
23. Miura M, Gabel D, Oenbrink G et al (1990) Preparation of carboranyl porphyrins for boron neutron capture therapy. Tetrahedron Lett 31:2247-2250
24. Phadke AS, Morgan AR (1993) Synthesis of carboranyl porphyrins: potential drugs for boron neutron capture therapy. Tetrahedron Lett 34:1725-1728
25. Oenbrink G, Jurgenlimke P, Gabel D (1988) Accumulation of porphyrins in cells in fl uence of hydrophobicity aggregation and protein binding. Photochem Photobiol 48:451-456
26. Rosenthal MA, Kavar B, Hill JS et al (2001) Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol 19:519-524
27. Vicente MGH, Edwards BF, Shetty SJ et al (2002) Syntheses and preliminary biological studies of four meso-tetra[( nido-carboranylmethyl) phenyl[ porphyrins. Bioorg Med Chem 10:481-492
28. Matsumura A, Shibata Y, Yamamoto T et al (1999) A new boronated porphyrin (STA-BX909) for neutron capture therapy: an in vitro survival assay and in vivo tissue uptake study. Cancer Lett 141:203-209
29. Ratajski M, Osterloh J, Gabel D (2006) Boron-containing chlorins and tetraazaporphyrins: synthesis and cell uptake of boronated pyropheophorbide A derivatives. Anti-Cancer Agents Med Chem 6:159-166
30. Ol'shevskaya VA, Evstigneeva RP, Luzgina VN et al (2001) Synthesis of closo-monocarbon carborane-substituted natural porphyrins. Mendeleev Commun 11:14-15
31. Hao E, Sibrian-Vazquez M, Serem W, Garno JC (2007) Synthesis, aggregation and cellular investigations of porphyrin-cobaltacarborane conjugates. Chem Eur J 13:9035-9042
32. Bauer C, Gabel D, Dörfler U (2002) Azanonaboranes [(RNH2)B8H11NHR] as possible new compounds for use in boron neutron capture therapy. Eur J Med Chem 37:649-657
33. Tjarks W, Anisuzzaman AKM, Liu L et al (1992) Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy. J Med Chem 35:1628-1633
34. Tietze LF, Bothe U (1998) Ortho-carboranyl glycosides of glucose, mannose, maltose and lactosefor cancer treatment by boron neutron-capture therapy. Chem Eur J 4:1179-1183
35. Tietze LF, Bothe U, Griesbach U et al (2001) ortho-Carboranyl glycosides for the treatment of cancer by boron neutron capture therapy. Bioorg Med Chem 9:1747-1752
36. Giovenzana GB, Lay L, Monti D et al (1999) Synthesis of carboranyl derivatives of alkynyl glycosides as potential BNCT agents. Tetrahedron 55:14123-14136
37. Stadlbauer S, Welzel P, Hey-Hawkins E (2009) Access to carbaboranyl glycophosphonates: an Odyssey. Inorg Chem 48:55005-55010
38. Ronchi S, Prosperi D, Thimon C et al (2005) Synthesis of mono-and bisglucuronylated carboranes. Tetrahedron Asymmet 16:39-44
39. El-Zaria ME, Genady AR, Gabel D (2006) Thefi rst synthesis of azanonaborane-containing sugars, possible boron carriers for neutron capture therapy. New J Chem 30:597-602
40. Endo Y, Iijima T, Yamakoshi Y et al (1999) Potent estrogenic agonists bearing dicarba-closododecaborane as a hydrophobic pharmacophore. J Med Chem 42:1501-1504
41. Endo Y, Iijima T, Yamakoshi Y et al (2001) Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters. Chem Biol 8:341-355
42. Julius RL, Farha OK, Chiang J et al (2007) Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores. Proc Natl Acad Sci USA 104:4808-4813
43. Lee C-H, Jin GF, Yoon JH et al (2008) Synthesis and characterization of polar functional group substituted mono-and bis-(o-carboranyl)-1, 3, 5-triazine derivatives. Tetrahedron Lett 49:159-164
44. Armstrong AF, Valliant JF (2007) The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. Dalton Trans 4240-4251
45. Barth RF, Adams DM, Soloway AH et al (1994) Boronated starburst dendrimer-monoclonal antibody immunoconjugates. Evaluation as a potential delivery system for neutron capture therapy. Bioconjug Chem 5:58-66
46. Shukla S, Wu G, Chatterjee M et al (2003) Synthesis and biological evaluation of folate receptor-targeted boronated pamam dendrimers as potential agents for neutron capture therapy. Bioconjug Chem 14:158-167
47. Yinghuai Z, Peng A, Carpenter K et al (2005) Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery. J Am Chem Soc 127:9875-9880
48. Hosmane NS, Yinghuai Z, Maguire JA et al (2009) Nano and dendritic structured carboranes and metallacarboranes: from materials to cancer therapy. J Organomet Chem 694:1690-1697
49. Azab A-K, Srebnik M, Doviner V, Rubinstein A (2005) Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers. J Control Release 106:14-25
50. Capala J, Barth RF, Bendayan M (1996) Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjug Chem 7:7-15
51. Barth RF, Yang W, Adams DM et al (2002) Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Res 62:3159-3166
52. Wu G, Barth RF, Yang W et al (2004) Site-speci fi c conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug Chem 15:185-194
53. Wu G, Yang W, Barth RF et al (2007) Molecular targeting and treatment of an epidermal growth factor receptor positive glioma using boronated cetuximab. Clin Cancer Res 13:1260-1268
54. Suzuki M, Sakurai Y, Masunaga S et al (2003) Study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors. Int J Radiat Oncol Biol Phys 58:892-896
55. Suzuki M, Nagata K, Masunaga S et al (2004) Biodistribution of 10 B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion. Appl Radiat Isot 61:933-937
56. Yanagie H, Higashi S, Ikushima I et al. (2006) Selective enhancement of boron accumulation with boron-entrapped water-in-oil-water emulsion in VX-2 rabbit hepatic cancer model for BNCT. In: Nakagawa Y, Kobayashi T, Fukuda H. (eds.) Proceedings of ICNCT-12:211-214
57. Kaneda Y, Yamamoto S, Hiraoka K (2003) The hemagglutinating virus of Japan-liposome method for gene delivery. Methods Enzymol 373:482-493
58. Nakai K, Yamamoto T, Matsumura A (2006) Application of HVJ envelop system to boron neutron capture therapy. In: Nakagawa Y, Kobayashi T, Fukuda H. (eds.) Proceedings of ICNCT-12:207-210
59. Yanagie H, Tomita T, Kobayashi H et al (1991) Application of boronated anti-cea immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br J Cancer 63:522-526
60. Yanagie H, Tomita T, Kobayashi H et al (1997) Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br J Cancer 75:660-665
61. Sherry K, Feakes DA, Hawthorne MF et al (1992) Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes. Proc Natl Acad Sci USA 89:9039-9043
62. Feakes DA, Shelly K, Knobler DB et al (1994) Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors. Proc Natl Acad Sci USA 91:3029-3033
63. Pan XQ, Wang H, Shukla S et al (2002) Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconjug Chem 13: 435-442
64. Kullberg EB, Carlsson J, Edwards K et al (2003) Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy. Int J Oncol 23:461-467
65. Maruyama K, Ishida O, Kasaoka S et al (2004) Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release 98:195-207
66. Yanagie H, Ogura K, Takaagi K et al (2004) Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography. Appl Radiat Isot 61:639-646
67. Masunaga S, Kasaoka S, Maruyama K et al (2006) The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-10 B (GB-10) as 10 B-carriers for boron neutron capture therapy. Int J Radiat Oncol Biol Phys 66:1515-1522
68. Pan X, Wu G, Yang W et al (2007) Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem 18:101-108
69. Feakes DA, Shelly K, Hawthornet MF (1995) Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc Natl Acad Sci USA 92:1367-1370
70. Nakamura H, Miyajima Y, Takei T et al. (2004) Synthesis and vesicleformation of a nidocarborane cluster lipid for boron neutron capture therapy. Chem Commun 1910-1911
71. Miyajima Y, Nakamura H, Kuwata Y et al (2006) Transferrin-loaded nido-Carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy. Bioconjug Chem 17:1314-1320
72. Li T, Hamdi J, Hawthrone MF (2006) Unilamellar liposomes with enhanced boron content. Bioconjug Chem 17:15-20
73. Lee J-D, Ueno M, Miyajima Y, Nakamura H (2007) Synthesis of boron cluster lipids: closo-Dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. Org Lett 9:323-326
74. Nakamura H, Lee J-D, Ueno M, Miyajima Y, Ban HS (2008) Synthesis of closo-dodecaboryl lipids and their liposomal formation for boron neutron capture therapy. NanoBiotechnology 3:135-145
75. Nakamura H, Ueno M, Ban HS et al (2009) Development of boron nano capsules for neutron capture therapy. Appl Radiat Isot 67:S84-S87
76. Justus E, Awad D, Hohnholt M et al (2007) Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy. Bioconjug Chem 18:1287-1293
77. Feakes DA, Spinler JK, Harris FR (1999) Synthesis of boron-containing cholesterol derivatives for incorporation into unilamellar liposomes and evaluation as potential agents for BNCT. Tetrahedron 55:11177-11186
78. Nakamura H, Ueno M, Lee JD et al (2007) Synthesis of dodecaborate-conjugated cholesterols for efficient boron delivery in neutron capture therapy. Tetrahedron Lett 48:3151-3154
79. Thirumamagal BTS, Zhao XB, Bandyopadhyaya AK et al (2006) Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy. Bioconjug Chem 17:1141-1150